Bigul

Procter & Gamble Health Ltd - 500126 - Shareholder Meeting / Postal Ballot-Outcome of AGM

We would like to inform you that the 55th Annual General Meeting of the Company was held on November 23, 2022 at 3.30 p.m. through Video Conference / Other Audio-Visual Means. In this respect, please find enclosed below: 1. Voting results in respect of the business conducted at the Annual General Meeting, as required under Regulation 44 (3) of the SEBI (Listing Obligations & Disclosure Requirements), Regulations, 2015; and 2. Scrutinizer's Report Kindly take the above on record and oblige.
24-11-2022
Bigul

Procter & Gamble Health Ltd - 500126 - Shareholder Meeting / Postal Ballot-Outcome of AGM

We would like to inform you that the 55th Annual General Meeting of the Company was held today, November 23, 2022 at 3.30 p.m. through Video Conference / Other Audio-Visual Means. In this respect, please find enclosed a summary of proceedings of the 55th Annual General Meeting. Further, we have enclosed copy of presentation on business review and overview on Corporate Social Responsibility activities of the Company presented at the 55th Annual General Meeting held today, i.e., November 23, 2022.
23-11-2022
Bigul

Procter & Gamble Health Ltd - 500126 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

We have been informed by our Registrars and Share Transfer Agents (RTA), KFin Technologies Limited on November 17,2022, regarding the loss /misplacement of the share certificate(s). We request you to take the same on record and acknowledge receipt.
18-11-2022
Bigul

Procter & Gamble Health Ltd - 500126 - Board Meeting Outcome for Unaudited Financial Results For The Quarter Ended September 30, 2022

We are pleased to inform you that at the meeting of the Board of Directors of the Company held today (started at 6 p.m. and concluded at p.m.), the Unaudited Financial Results for the quarter ended September 30, 2022 were approved. We are enclosing herewith the following: a. Unaudited Financial Results for the quarter ended September 30, 2022; b. Press Release; and c. Limited Review Report in respect of the Unaudited Financial Results for the quarter ended September 30, 2022 furnished by Statutory Auditors of the Company Kindly take the same on record and oblige.
11-11-2022
Bigul

Procter & Gamble Health Ltd - 500126 - Unaudited Financial Results For The Quarter Ended September 30, 2022

We are pleased to inform you that at the meeting of the Board of Directors of the Company held today (started at 6.25 p.m. and concluded at 7.15p.m.), the Unaudited Financial Results for the quarter ended September 30, 2022 were approved. We are enclosing herewith the following: a. Unaudited Financial Results for the quarter ended September 30, 2022; b. Press Release; and c. Limited Review Report in respect of the Unaudited Financial Results for the quarter ended September 30, 2022 furnished by Statutory Auditors of the Company Kindly take the same on record and oblige.
11-11-2022
Bigul

Procter & Gamble Health Ltd - 500126 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

We have been informed by our Registrars and Share Transfer Agents (RTA), KFin Technologies Limited on November 02,2022, regarding the loss /misplacement of the share certificate(s). We request you to take the same on record and acknowledge receipt
02-11-2022
Bigul

Procter & Gamble Health Ltd - 500126 - Reg. 34 (1) Annual Report.

We refer to our letter dated September 8, 2022, intimating the date of 55th Annual General Meeting. In this respect, please find enclosed Annual Report for the Financial Year ended June 30, 2022 and Notice calling the 55th Annual General Meeting of the Company. In accordance with, the General Circular No. 02/2022 issued by MCA and Circular No. SEBI/HO/CFD/CMD2/CIR/P/2022/62, the Annual Report for the Financial Year 2021-22, including the Notice of AGM has been sent in electronic mode to Members today, October 31,2022, whose e-mail addresses are registered with the Company. The copy of the Notice along with the Annual Report is enclosed herewith and is also available on the Company's website: https://www.pghealthindia.com/investors/. Kindly take the same on record and oblige.
31-10-2022
Bigul

Procter & Gamble Health Ltd - 500126 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

With reference to above captioned subject, on the basis of confirmation received from our Registrar and Transfer Agent, Kfin Technologies Limited ( formerly known as Kfin Technologies Private Limited), we confirm that the details of securities dematerialised during the quarter ended September 30,2022 as required under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, have been furnished to the stock exchanges where the shares of the Company are listed within the prescribed time period. We enclose herewith the copy of letter received from Kfin Technologies Limited confirming the above.
21-10-2022
Bigul

Procter & Gamble Health Ltd - 500126 - Update on board meeting

The Board Meeting to be held on 09/11/2022 has been revised to 11/11/2022 With reference to the announcement dated October 7, 2022 and in terms of Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015, we wish to inform you that the meeting of the Board of Directors of the Company is now rescheduled to be held on Friday, November 11, 2022, inter alia, to consider and approve the unaudited financial results for the quarter ended September 30, 2022
17-10-2022
Bigul

Procter & Gamble Health Ltd - 500126 - Board Meeting Intimation for November 9, 2022

Procter & Gamble Health Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/11/2022 ,inter alia, to consider and approve the unaudited financial results for the quarter ended September 30, 2022.
07-10-2022
Next Page
Close

Let's Open Free Demat Account